These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 1838693)
21. Antihypertensive, enzymatic, and hormonal activity of cilazapril, a new angiotensin-converting enzyme inhibitor in patients with mild to moderate essential hypertension. Sánchez RA; Traballi CA; Barclay CA; Gilbert HB; Muscará M; Giannone C; Moledo LI J Cardiovasc Pharmacol; 1988 Feb; 11(2):230-4. PubMed ID: 2452319 [TBL] [Abstract][Full Text] [Related]
22. Cilazapril: an overview of its efficacy and safety in hypertension. Szucs T; Schneeweiss A Cardiology; 1992; 80(1):34-41. PubMed ID: 1532534 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of cilazapril, a new angiotensin-converting enzyme inhibitor. Goldszer RC; Rodriguez R; Solomon HS Am J Hypertens; 1988 Jul; 1(3 Pt 3):300S-302S. PubMed ID: 2970856 [TBL] [Abstract][Full Text] [Related]
24. Does the combination of cilazapril and propranolol lower blood pressure at rest and during exercise more pronouncedly than either of the two components given alone? Erb KA; Breithaupt K; Kleinbloesem CH; Wolf GK; Belz GG Clin Physiol Biochem; 1990; 8 Suppl 2():35-45. PubMed ID: 2151315 [TBL] [Abstract][Full Text] [Related]
25. Influence of metoprolol and cilazapril on blood pressure and on sleep apnea activity. Mayer J; Weichler U; Herres-Mayer B; Schneider H; Marx U; Peter JH J Cardiovasc Pharmacol; 1990 Dec; 16(6):952-61. PubMed ID: 1704989 [TBL] [Abstract][Full Text] [Related]
26. Effects of nitrendipine and cilazapril on renal hemodynamics and albuminuria in hypertensive patients with chronic renal failure. Kloke HJ; Wetzels JF; van Hamersvelt HW; Koene RA; Kleinbloesem CH; Huysmans FT J Cardiovasc Pharmacol; 1990 Dec; 16(6):924-30. PubMed ID: 1704985 [TBL] [Abstract][Full Text] [Related]
27. Influence of the angiotensin converting enzyme inhibitor cilazapril, the beta-blocker propranolol and their combination on haemodynamics in hypertension. Belz GG; Breithaupt K; Erb K; Kleinbloesem CH; Wolf GK J Hypertens; 1989 Oct; 7(10):817-24. PubMed ID: 2531184 [TBL] [Abstract][Full Text] [Related]
28. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension. Whelton A; Dunne B; Glazer N; Kostis JB; Miller WE; Rector DJ; Tresznewsky ON J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444 [TBL] [Abstract][Full Text] [Related]
29. Characteristics of the effects of the angiotensin converting enzyme inhibitor cilazapril on diurnal blood pressure. Nakanishi T; Takahashi H; Nishimura M; Yoshimura M Clin Ther; 1993; 15(2):294-303. PubMed ID: 8519038 [TBL] [Abstract][Full Text] [Related]
30. Cilazapril inhibits vascular responses to baroreflex-stimulated sympathetic neural activity in hypertensive patients. Fernandez PG; Bolli P; Lee C; Vasdev S Can J Cardiol; 1990; 6(1):9-14. PubMed ID: 2138049 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of cilazapril compared with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension. Multicentre Study Group. Morgan TO Am J Med; 1989 Dec; 87(6B):37S-41S. PubMed ID: 2532459 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of single and consecutive doses of cilazapril and its depressor effects in patients with essential hypertension. Shionoiri H; Gotoh E; Miyakawa T; Takasaki I; Oda H; Ueda S; Kaneko Y Am J Hypertens; 1988 Jul; 1(3 Pt 3):269S-273S. PubMed ID: 2970854 [TBL] [Abstract][Full Text] [Related]
33. Effects of chronic cilazapril treatment on cardiovascular control: a spectral analytical approach. Pagani M; Pizzinelli P; Mariani P; Lucini D; di Michele R; Malliani A J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S110-6. PubMed ID: 1382158 [TBL] [Abstract][Full Text] [Related]
34. The effect of cilazapril on systolic and diastolic cardiac function in hypertensive patients. Schneeweiss A; Green T; Krakuer J; Goldhamer E; Szucs T; Marmor A J Hum Hypertens; 1989 Aug; 3(4):251-4. PubMed ID: 2529375 [TBL] [Abstract][Full Text] [Related]
35. Effects of angiotensin-converting enzyme inhibition versus beta-adrenergic blockade on aortic stiffness in essential hypertension. Savolainen A; Keto P; Poutanen VP; Hekali P; Standertskjöld-Nordenstam CG; Rames A; Kupari M J Cardiovasc Pharmacol; 1996 Jan; 27(1):99-104. PubMed ID: 8656666 [TBL] [Abstract][Full Text] [Related]
36. Antihypertensive effects of nitrendipine and cilazapril alone, and in combination in hypertensive patients with chronic renal failure. Kloke HJ; Huysmans FT; Wetzels JF; Sluiter HE; Kleinbloesem CH; Koene RA Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):289S-296S. PubMed ID: 2527541 [TBL] [Abstract][Full Text] [Related]
37. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring. Palma-Gamiz JL; Pêgo M; Marquez E; Pujol M; Olivan J; Alegría E; Sagastagoitia-Gorostiza JD; Gonzalez-Juanatey JR Clin Drug Investig; 2007; 27(6):407-17. PubMed ID: 17506591 [TBL] [Abstract][Full Text] [Related]
38. Cilazapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular disease. Deget F; Brogden RN Drugs; 1991 May; 41(5):799-820. PubMed ID: 1712710 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of cilazapril in hypertensive patients with moderate to severe renal impairment. Carlsen JE; Hansen FM; Jensen HA Am J Med; 1989 Dec; 87(6B):79S-82S. PubMed ID: 2532466 [TBL] [Abstract][Full Text] [Related]
40. Antihypertensive effect of cilazapril in essential hypertensive patients. Clinical study with 24 h ambulatory blood pressure monitoring. Hiwatari M; Abe K; Yoshinaga K; Saito T Arzneimittelforschung; 1991 Nov; 41(11):1137-40. PubMed ID: 1839765 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]